Comments

Vanda Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Vanda Pharmaceuticals (VNDA) operate in?

Vanda Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VNDANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.77

-0.15-3.05%

At close: -

$4.83

0.061.26%

After Hours: Mar 21, 6:15 PM EDT

Vanda Pharmaceuticals (VNDA) Forecast

News Earnings Vanda Pharmaceuticals (VNDA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Vanda Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VNDA | Benzinga

Explore Vanda Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VNDA.

Open	$4.95
Close	$4.77
Volume / Avg.	606.84K / 627.87K
Day Range	$4.75 - $4.96
52 Wk Range	3.71 - 6.75
Market Cap	$281.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	6.79%
Days to Cover	4.55

Recent News

FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate

FDA denies Vanda's Tradipitant application for gastroparesis, urging new trials for efficacy and safety. Vanda disputes the agency's review process.

Vandana Singh

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology.

Vandana Singh

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) announced that the FDA issued a complete response letter to its new drug application (NDA) seeking approval for its pipeline candidate, tradipitant for the treatment of symptoms in gastroparesis.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.95
Close	$4.77
Volume / Avg.	606.84K / 627.87K
Day Range	$4.75 - $4.96
52 Wk Range	3.71 - 6.75
Market Cap	$281.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	6.79%
Days to Cover	4.55

About Vanda Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercializ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vanda Pharmaceuticals (VNDA) stock?

You can purchase shares of Vanda Pharmaceuticals (NASDAQ:VNDA) through any online brokerage.

View our list of the best stock brokerages

Who are Vanda Pharmaceuticals (VNDA) competitors?

Other companies in Vanda Pharmaceuticals’s space includes: Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA), Design Therapeutics (NASDAQ:DSGN) and Emergent BioSolutions (NYSE:EBS).

What is the forecast, or price target, for Vanda Pharmaceuticals (VNDA) stock?

Vanda Pharmaceuticals has a consensus price target of $16.50.

What is the current price for Vanda Pharmaceuticals (VNDA)?

The stock price for Vanda Pharmaceuticals (NASDAQ: VNDA) is $4.8301 last updated March 21, 2025 at 6:15 PM EDT.

Does Vanda Pharmaceuticals (VNDA) pay a dividend?

There are no upcoming dividends for Vanda Pharmaceuticals.

When is Vanda Pharmaceuticals (NASDAQ:VNDA) reporting earnings?

Vanda Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Vanda Pharmaceuticals (VNDA) going to split?

There is no upcoming split for Vanda Pharmaceuticals.

What sector and industry does Vanda Pharmaceuticals (VNDA) operate in?

Vanda Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.